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Between July 1975 and April 1980, 71 patients were admitted to the Second Attached
Hospital of Hubei Provincial Medical College in Wuchang with the diagnosis of epidemic
hemorrhagic fever(EHF). Theclinical course amongthesepatients was similar to that described
for patients with Korean hemorrhagic fever, and hemorrhagic fever with renal syndrome ofthe
U.S.S.R. The overall mortality was 11.2 percent. Sera obtained from some of these patients as
well as from patients admitted to the First Attached Hospital of Hubei Provincial Medical
College were tested against an antigen associated with Korean hemorrhagic fever and showed
exceedingly high antibody titers. We conclude that EHF in Central China represents the same
or a closely related disease process as Korean hemorrhagic fever.
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Epidemic hemorrhagic fever (EHF) is a syndrome characterized by sequential
periods of fever, hypotension, oliguria, and polyuria which is often accompanied by a
hemorrhagic diathesis early in the course of the illness [1,2]. During the Korean War
(1950-52), this disease process represented a major source ofmorbidity and mortality
for American armed forces [1-7]; at that time massive research efforts to define the
etiologic agent were unsuccessful [4,8] although understanding of the disease [8,9]
and treatment methods were improved [10].
Since that time, whereas information regarding EHF in northern Europe
[3,4,11,12-14], the USSR [2,3,4,15], and Korea has become available [16,17], little is
known about EHF in the People's Republic of China (PRC). Recent agreements
between the governments of the PRC and the United States of America [18] have
allowed investigators from this country to participate in research efforts in the PRC
[19]. Between November 1979 and April 1980 one of the authors (MSC) lived and
worked at Hubei Provincial Medical College and was afforded the opportunity to
become involved in the management of patients with EHF [19]. (Three other of the
authors [DCG, CJG, and PWL] initiated collaborative studies with Professor Z.-Y.
Xu of the First Shanghai Medical School, and Professor C.-M. Hsiang of Hubei
Provincial Medical College, and together established the antigenic relationship ofthe
disease in China with that ofKorea[20,21].) Subsequently, serafrom the same Hubei
patient population were investigated in virologic laboratories at Yale University
School of Medicine, the West Haven Veterans Administration Medical Center, and
the National Institutes of Health [21]. The results ofthese studies are included in this
report.
MATERIALS AND METHODS
Patient Population
All patients admitted to Hubei Provincial Medical College's Second Attached
Hospital with the diagnosis of EHF between November 1979 and April 1980 were
seen and evaluated by two of the authors (MSC, HSK). Records ofpatients with the
discharge diagnosis of EHF seen at the same facility between July 1975 and April
1980 were evaluated in collaboration with investigators and translators from Hubei
Provincial Medical College.
Sera Specimens
Acute and convalescent sera were obtained from patients admitted to the Infec-
tious Disease Ward of the First or Second Attached Hospitals of Hubei Provincial
Medical College. Acute sera were collected between the fourth and seventh (mean
5.8) day of illness, whereas convalescent sera were collected between thetwenty-third
and thirty-ninth (mean 31) day of illness. Sera were stored at -20°C until tested,
except during intercontinental transport.
Serological Tests
Hemagglutination-inhibition tests against various viral antigens associated with
Murray Valley, Japanese B encephalitis, yellow fever, Omsk hemorrhagic fever, and
chikungunya viruses by methods previously described [22] were performed on single
and paired serum samples in the Yale Arbovirus Research Unit (YARU) laboratory,
Department of Epidemiology and Public Health, Yale University School of Medi-
cine.
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Indirect immunofluorescence tests to detect antibodies against Korean hemor-
rhagic fever (KHF) virus were performed at the NIH laboratories where this virus
and the related neuropathia epidemica antigen are available for specific antibody
studies [13,14,21,27]. Two kinds of antigen preparations were used: a human lung
cancer cell-line, A-549, infected with KHF virus originally isolated by Lee et al. [16]
and adapted to cell culture by French et al. (personal communication), and a
Wistar rat lung tissue infected with KHF virus, strain 118/AP
* 7 [23]. After the
addition of serial dilutions of the patient sera to acetone-fixed infected cells, slides
were allowed to incubate at 370C in a humidified chamber for 30 minutes. Then the
excess serum was removed by washing with phosphate buffered saline, pH 7.2; a
fluorescein conjugated antihuman IgG prepared in goat (Cappel) was added, and an
additional 30 minutes' incubation was allowed. Control sera with known positive and
negative antibody titers to KHF virus and two monkey sera previously shown to have
high antibody titers to simian hemorrhagic fever virus were included in the same test.
RESULTS
Three cases which emphasize the spectrum of disease associated with EHF are
described below. In addition, these case reports offer a view of the health care
delivery system in the People's Republic of China.
Case A
Case 144599 is a 19-year-old Chinese female. She had no history of prior illness.
She was employed as a field worker in a suburban commune; between November 21
and December 2, 1979, she participated in a water irrigation project near her home.
She was well until December 12th when she noted the acute onset of a fever of
400C, back pain, nausea, and vomiting. In addition she noted pain over the frontal
sinuses and was observed to be slightly confused. Eleven other workers participated
in the same irrigation project, but reported no problems. She was seen on the first day
of her illness in the commune clinic where she was treated with IV fluids, penicillin,
and streptomycin. Shefailed to improve and five days after the onset of her illness she
was transferred to the Second Attached Hospital. On the day of transfer, her urine
output was 460 cc. Over 24 hours, her axillary temperature was 380C, but blood
pressure and respiration were normal. Physical examination revealed marked facial
flushing (see Fig. 1) and petechiae over the chest and in the axillae. She had
conjunctivitis and eyelid edema. The remainder of the examination was unremark-
able except for slight agitation. The white blood count was 24,100/mm3 with 25
percent neutrophils, 62 percent lymphocytes, 8 percent monocytes, and 5 percent
atypical lymphocytes. The platelet count was 57,000/mm3. Blood urea nitrogen was
57 mg%/0 and PTT and PT were normal. Urinalysis revealed many white blood cells,
1+ protein and red blood cells too numerous to count. The fibrinogen level was 95
mg%0 (normal 200-400 mg%/), and an electrocardiogram was normal.
Although the patient had persistent fever, oliguria (urine output less than 500
cc/24 hours) was short-lived. She was treated with hydrocortisone 100 mg IV,
phytohemagglutinin 20 mg IV, vitamin C, furosemide, ethacrynic acid, chloramphen-
icol, and potassium chloride. Urine output remained in the normal range until the
seventh day after admission at which time polyuria developed. Polyuria lasted nine
days and was managed with fluid and electrolyte replacement. Repeat laboratory
examination revealed a normal hemoglobin, leukocyte count, platelet count, and
urinalysis; all symptoms abated. The patient was discharged 44 days after the onset of
illness and returned to her commune. Sera obtained six days after the onset of illness
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FIG. 1. Case A who presented
marked facial edema and flush-
ing characteristic of EHF.
(acute) and 31 days after the onset of her illness (convalescent) were assessed for
antibodies against antigens associated with KHF bythe indirect immunofluorescence
test (see Methods). The acute serum reacted at a dilution of 1:128 and the convales-
cent sera reacted at a dilution of 1:8192. The patient's sera did not react positively
with any of the arbovirus antigens against which they were tested (see Results).
Comment
This patient presented with rather typical findings of EHF, although the fever
phase was prolonged for 13 days. She did not have hypotension or shock but did have
one day of oliguria. She subsequently had nine days of polyuria. Her confusion
emphasizes the central nervous system involvement which we observed among
patients with this disease; lumbar puncture was not performed. (The serological
response observed will be discussed below.)
Case B
Patient 144893 was a 40-year-old Chinese female. She was well until December 15
when she noted the sudden onset ofchills, fever, nausea, and myalgias. She was seen
almost immediately by a "barefoot" doctor and treated with unknown medications.
Four days later she was admitted to the commune hospital with the diagnosis of
EHF; fluids, dextran, hydrocortisone, and bicarbonate were administered. Three
days after admission to the commune hospital the patient became confused, and
hypotension and oliguria developed. At that time she was transferred to the Second
Attached Hospital of Hubei Provincial Medical College. On admission to that
facility the temperature was 370C, the blood pressure was 60/30 mmHg, the pulse
was 140 per minute, and the patient was disoriented in all spheres. Physical
examination revealed marked conjunctivitis and swelling about the eyelids. In
addition blood oozed from an intravenous cutdown site in the right leg, but no other
abnormalities in the physical examination were observed. Laboratory evaluation
revealed a white blood count of 74,400/mm3 with 60 percent neutrophils, 12 percent
lymphocytes, and 28 percent atypical lymphocytes. The hemoglobin was 13.0 g/dl;
the platelet count was 63,000 per mm3. Urinalysis revealed red blood cells too
numerous to count, 10-20 white blood cells per high power field, and 2+ protein. On
the day following admission the patient developed respiratory insufficiency. Rales
were heard at both bases and the respiratory rate was 50 per minute. In addition,EPIDEMIC HEMORRHAGIC FEVER IN THE PRC
swelling about the neck was observed. Laboratory examinations at this time revealed
a hemoglobin of 7.25 gm and a blood urea nitrogen of 102 mg%o. The patient was
treated with furosemide, vitamin C, ethacrynic acid, penicillin G, and gentamicin.
Over the subsequent 24 hours the swelling about the patient's neck increased
dramatically, as did her respiratory distress (see Fig. 2). She died on the fourth
hospital day.
Comment
This patient had 11 days of fever, two days of hypotension and shock, and two
days ofoliguria. Subsequently her urine output was normal until death. Although she
had only slight peripheral edema the dramatic swelling about her neck and probable
pulmonary edema led to her demise. Inability to maintain fluid in the intravascular
space is characteristic of EHF [2,7] and contributes to the very difficult fluid
management of these patients.
Case C
Patient 145380 is a 42-year-old male worker. He had excellent health untilJanuary
11, 1980, at which time he developed fever of 38.60C and submandibular lymphade-
nopathy. He was seen in the outpatient department ofthe Second Attached Hospital
and was given a Chinese traditionalmedicine, tetracycline, and aspirin. Subsequently
he remained stable overthe next twodays until he developed crampyabdominal pain
and diarrhea. In addition he had nausea and vomiting; coffee ground emesis was
noted. At that time he was admitted to the Second Attached Hospital. Physical
examination revealed blood pressure of 70/0 mmHg, pulse of 90 per minute, and
temperature of 390C. Erythema of the pharynx was noted and the laboratory
examination revealed hemoglobin of 12 g/dl, leukocyte count of 18,600 with 84
percent neutrophils and 16 percent lymphocytes. Blood urea nitrogen was 44 mg%0,
and potassium was slightly depressed. Gastric contents were aspirated and were 2+
positive for blood. The patient was treated with fluids, bicarbonate, and vitamin C.
His abdominal pain did not resolve and on the day following admission gastroscopy
was performed. This examination revealed acute diffuse gastritis without a focal
ulcer. The blood pressure was stable with fluid replacement but the patient's urine
output decreased dramatically on the third hospital day. Examination of the urine
revealed 4+ protein, gross hematuria, and leukocytes with white blood cell casts.
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massive neck edema (outlined by
arrows) shortly before her death,
presumably secondary to the vas-
cular damage associated with
EHF.
45Blood urea nitrogen was 72 mg%/ and the CO2 combining power was slightly
depressed. The patient was treated with dihydrocortisone and furosemide vice lasix.
Evaluation of the coagulation status revealed a platelet count of 92,000 per mm3 and
prolonged clotting time and bleeding time. In addition, the patient developed
confusion and seizures which were attributed to uremia. Concomitantly the patient
developed marked facial and periorbital edema about the eyelids. At that time the
diagnosis of EHF was entertained. Subsequently on the fifth hospital day the patient
developed polyuria which persisted more than 40 days. His other symptoms im-
proved and all laboratory examinations returned to normal.
Comment
This case emphasizes the difficulty in making the diagnosis of EHF in the absence
of a classical presentation. The patient's sequential fever, hypotension, and acute
renal failure were attributed to gastritis, shock, and acute renal failure rather than
considered as a single syndrome. In addition the patient's central nervous system
abnormalities most probably were related to the disease process itself rather than to
uremia.
Clinical Studies
Between July 1975 and April 1980, 71 patients were admitted to the First Attached
Hospital with the diagnosis of EHF(Fig. 3). Eighty percent ofthe patients developed
this illness between November and February. The age of the patients ranged from 13
to 69 with a mean of 38.0 ± 13.2 years (mean ± standard deviation). There were 49
males and 22 females. Occupations included commune workers (46), laborers (9),
students (5), administrative officials (2), teachers (2), and technicians (2); the
occupation was not known for five of the patients.
The most common signs and symptoms of the illness are shown in Table 1.
Whereas most symptoms were nonspecifc (e.g., fever, myalgias, diarrhea), facial
flushing, axillary petechiae, and conjunctival edema, often with eyelid swelling, were
considered highly suggestive of EHF. Unfortunately, these latter symptoms occurred
in 50 percent or less of the patients. The "three pains" of EHF-headache, orbital
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FIG. 3. Month of admission of patients with EHF to the Second Attached Hospital of
HPMC, July 1975-March 1980.
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TABLE 1
Signs and Symptoms Associated with EHF at the Time of Admission (Total, 71 cases)
Number of
patients (%)
Fever 71 100
Headache 59 83
Palatal injection 58 82
Nausea 51 72
Costovertebral angle pain 49 69
Conjunctivitis 45 64
Vomiting 41 58
Axillary petechiae 40 56
Myalgia 39 55
Flushing 30 42
Weakness 30 42
Dizziness 29 41
Diarrhea 26 37
Orbital pain 24 34
Bleeding
a 22 31
Chest Petechiae 21 30
Abdominal pain 18 25
Conjunctival edema 16 23
Ecchymosis 15 21
Blurred vision 13 18
Eyelid edema 12 17
Confusion 11 16
Abdominal tenderness 11 16
Rhonchi, wheezes 7 10
Rales 5 7
Lymphadenopathy 2 3
Ankle edema 2 3
aBleeding from venipuncture site, gastrointestinal tract, and/or epistaxis.
pain, and back pain-were observed in 83 percent, 34 percent, and 69 percent of
patients, respectively.
Regardless of the frequency of the disease in Hubei Province, the diagnosis was
rarely made during the initial medical contact. As outlined in Fig. 4, although
NUMBER OF
PATIENTS
EVALUATED
DURATION OF HOSPITALIZATION (68) ~~AT HPMC
(71) Wq DAYS UNTIL HOSPITALIZATION (71) ~~AT HPMC
(61) DAYS UNTIL CORRECT DIAGNOSIS
(39)
4 DAYS UNTIL FIRST MEDICAL CONTACT
2 4 6 8 10 12 14 16 18 20 22 24 '26
DAYS
FIG. 4. The temporal sequence of events associated with EHF among patients admitted to
the Second Attached Hospital are shown.
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The Phases of EHF among 71 Patients
No. Duration Range
Phase No. Pts (% total) Evaluable (days) (days)
Fever (>37.6°C axillary) 71 (100) 57/71 7.4 + 3.8 2-15
Hypotension (<90/60 mm Hg) 30 (42) 29/30 1.3 + 0.67 0.5-3
Oliguria (<500 cc urine/24 hr) 42 (59) 38/42 2.8 + 2.1 1-10
Polyuria (>2,000 cc urine/24 hr) 64 (87)a 29/64b 14.8 + 8.2 1-35
a87 percent may be lower than expected because six patients died prior to the polyuria phase and one
patient remained in the hospital at the termination of this study.
bPatients discharged with urine output greater than 2,500 cc/24 hours could not be evaluated.
patients were seen by a health worker within two or three days after onset of illness,
the correct diagnosis was not entertained until the second or third visit.
The frequency and duration of the expected phases of the disease are shown in
Table 2. Although 100 percent of the patients had a fever phase, hypotension and
oliguria were reported in only 42 percent and 59 percent ofthe patients, respectively.
Polyuria was observed in all patients in whom this could be evaluated.
A summary of some of the abnormal laboratory results encountered is shown in
Tables 3 and 4. Ninety-two percent ofthe patients had leukocyte counts greater than
10,000 per mm3 at some time during the disease. Fifty percent of the patients had
atypical lymphocytes on differential examination. Eleven percent of the patients had
myelocytes or metamyelocytes observed in the peripheral blood smear. Platelet
counts were depressed in 78 percent of the patients examined. The nadir ofthe plate-
let count occurred during the fever phase in one-third ofthe patients, and in the early
polyuria phase' or polyuria phase in 44 percent of the patients. The blood urea
nitrogen (BUN) was elevated during all phases ofthedisease. BUN was highest in the
oliguria phase (73.7 ± 20.3 mg%O, n = 15) and remained elevated during the polyuria
phase (55.4 ± 22.9 mg%O) in 59 patients in whom this parameter was assessed. The
blood urea nitrogen returned to near normal (22.9 ± 13.21, n = 5) before discharge.
Electrolyte abnormalities were common, as shown in Table 4, but were rarely severe.
Abnormalities in the urine including hematuria, pyuria, and proteinura were
invariable findings; red and white blood cell casts were also seen on occasion.
Epidemic hemorrhagic fever was associated with severe morbidity and mortality.
The mean duration of illness was 29.4 ± 11.8 days (range 3-67 days, n = 68) and the
'Early polyuria refers to the state ofillness wherein oliguria has resolved but polyuria has not yet ensued
and urine output is normal.
TABLE 3
Laboratory abnormalities observed in 71 patients with EHFa
Maximal Neutrophil Platelet Nadir
Phase of Disease Maximal BUN (mg%) Count (x 103/mm3) (x 103/mm3)
Fever 47.9 h 18.7 (36)a 20.7 X 14.8 (41) 70.7 ± 44.1 (28)
Hypotension 46.2 i 13.34 (18) 16.5 + 10.7 (7) 68.0 (1)
Oliguria 73.7 20.3 (15) 25.5 + 16.5 (4) 136 f 75.0 (2)
Polyuria 55.4 + 29.9 (59) 10.3 + 4.0 (50) 102.4 ± 55.8 (38)
aValues are expressed as the mean and standard deviation of the mean of the number of samples
shown in parenthesis.
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TABLE 4
Serum Electrolyte Imbalances in 71 Patients with EHF0
CO2 K+ Ca++
Phase of Disease I I t I t I
Fever 0/36 29/36 0/30 15/30 0/26 16/26
Hypotension 0/18 17/18 2/14 3/14 0/12 4/12
Oliguria 0/21 17/21 2/19 4/19 0/18 7/18
Polyuria 0/59 44/59 4/60 21/60 0/57 34/57
aAn increase (t) or decrease (l) in serum carbon dioxidecombining power(CO2), potassium (K+), and
calcium (Ca++) are shown (numerator) among the patients in whom these parameters were evaluated
(denominator).
Normal values are as follows: C02, 24-30 meq/L; K+, 3.5-5.0 meq/L; and Ca", 9-11 mg/dl (con-
verted from Chinese units of measurement).
duration of hospitalization was 23.4 ± 10.7 days (range 1-48, n = 68, Fig. 1). The
mortality among patients admitted to Hubei Provincial Medical College between
1975 and 1980 ranged from 4.5 percent to 30 percent per year with a mean of 11.2
percent. Circumstances associated with the death of the patients are shown in
Table 5.
Serological Studies
Serum samples collected from patients hospitalized in both the First and Second
Attached Hospitals were brought to the United States for testing by one of the au-
TABLE 5
Cause of Death among 8 Patients with EHF
Day of
Patient Age Sex Illness Phase Sequelae Preceding Death
1 56 M 31 polyuria Pulmonary edema, anisocoria, persistent fever
(? 2° infection); BUN 21 mg0o, K' low
2 55 F 6 hypotension Patient died immediately after transfer; past
(shock) history of hypertension and nephritis; no
laboratory data available
3 60 M 14 polyuria Severe anemia, persistent leukocytosis, coma,
and nuchal rigidity preceding death; BUN
100 mg%; electrolytes normal
4 46 M 13 oliguria Anisocoria, CSF "yellow," BUN 96 mg%,
Ca" low
5 42 M 15 early Confusion, nuchal rigidity, anisocoria,-fever,
polyuriaa BUN 116 mg%, acidosis
6 39 M 3 hypotension BUN 54 mg%, acidosis
(shock)
7 41 M 13 ? History of hemoptysis; patient died
immediately after transfer to HPMC; no
laboratory data available
8 40 F 23 early Confusion and convulsions, pulmonary
polyuriaa infiltrates and "bull neck" (see Fig. 2);
BUN 98 mg%
aEarly polyuria refers to a brief period of normal urine output which follows oliguria and precedes
frank polyuria.
49thors (CMH). Positive immunofluorescence was observed in A 549 cells and frozen
and fixed sections of rat lung tissue infected with KHF virus strain 118 when tested
by the indirect immunofluorescence technique as shown in Fig. 5. Exceedingly high
antibody titers (1:4096-1:8192) were observed in convalescent serum samples ob-
tained 19-43 days after the onset of illness (Table 6). Less marked elevation in
antibody titers (1:128-1:256) were also noted inthree acute phase specimens obtained
6-7 days after the onset of illness. In control experiments employing a hemag-
glutination-inhibition assay, low titers of antibodies directed against Japanese B en-
cephalitis antigen (10 patients) and Murray Valley encephalitis antigen (five pa-
tients) were detected (Table 6); such low titered reactions are not considered diag-
nostic of recent infection with these agents.
DISCUSSION
Although specific information concerning the incidence of epidemic hemorrhagic
fever in the PRC is not available, the disease occurs in at least 18 provinces [24].
Between July of 1975 and April of 1980, 71 cases of Epidemic Hemorrhagic Fever
were admitted to the Second Attached Hospital of Hubei Provincial Medical
College. The majority ofcases occurred duringthewinter months between November
and February. This observation differs considerably from seasonal occurrence ofthe
disease in Korea where peaks have been observed in the summer months [4,5,25] and
the late fall [4,5,17,25-27].
In this study, the disease was twice as common among men compared to women
and did not occur in young children and infants. Although this pattern may relate
to risk factors associated with host defenses, it is more likely that exposure of male
laborers to the infectious agent accounts for this observation [26]. In other reported
series with male predominance, military populations were involved [1].
The initial symptom ,omplex ofEHF was difficult to distinguish from otherfebrile
illnesses. The subsequlent full-blown picture of the disease, however, was quite
characteristic. Constitutional symptoms included fever, headache, myalgia, and
weakness. More specific complaints including orbital pain, conjunctivitis, axillary
petechiae, facial flushing, and costovertebral angle tenderness occurred frequently,
but were not seen in every case. The symptom complex observed among Chinese
patients was nearly identical to that recorded among American soldiers who
developed EHF during the Korean War [1] and reports of the disease from the
FIG. 5. An A-549 cell culture
infected with KHF virus over-
layed with convalescent serum
obtained from patient (case A)
i4-.. 7]~7'- showing positive immunofluores-
cence.
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TABLE 6
KHF and other Viral Antibody Titers in sera obtained from Chinese EHF patients
FAb
Days After Hemagglutination-Inhibition Testa7
Serum Onset Acute/ KHF
Sample of Illness Conv. JE MVE YF OHF CHIK Virus
Paired 5 A 10 10 10 10 10 ND
19 C 10 10 10 10 10 ND
4 A 20 10 10 10 10 ND
35 C 20 10 10 10 10 ND
7 A 20 10 10 10 10 256
25 C 80 20 10 10 10 8,192
6* A 10 10 10 10 10 128
31 C 10 10 10 10 10 8,192
Single 7 A ND ND ND ND ND 256
NA** C 20 10 10 10 10 8,192
NA C 80 10 10 10 10 8,192
NA C 20 20 10 10 10 8,192
NA C 80 20 10 10 10 8,192
NA C 20 10 10 10 10 4,096
NA C 40 20 10 10 10 8,192
23 C 10 10 10 10 10 8,192
43 C 20 20 10 10 10 ND
39 C 10 10 10 10 10 ND
36 C 10 10 10 10 10 ND
28 C 20 10 10 10 10 8,192
aTested at YARU
JE, Japaneseencephalitis; MVE, MurrayValleyencephalitis; YF, yellow fever; OHF, Omsk hemor-
rhagic fever; CHIK, chikungunya; titers are expressed as the reciprocal of the highest dilution of
serum that inhibited hemagglutination of red blood cells by 4-8 units of antigen.
bTested at NIH by the indirect immunofluorescence test. Titers are expressed as the reciprocal of the
highest dilution of serum giving a 2+ or greater reaction.
*Case A under results
**NA, not available
USSR [4,15,28]. The vague initial symptom complex, however, made early
diagnosis somewhat difficult, and diagnosis was rarely made at the initial medical
contact.
EHF among Chinese patients was characterized by phases of fever, hypotension,
oliguria, and polyuria. Surprisingly, only 20 percent of the patients had a defined
period of hypotension, and slightly more than half had oliguria. This observation is
important because Chinese investigators attempting to improve the treatment of
EHF often gauge the success of their therapy on the duration or extent of the
expected phases. In particular, the absence of a phase of disease (e.g., a hypotensive
period followed by polyuriawith no oliguria) seemingly linked to a particular form of
therapy might be used as evidence of efficacy. Few studies have been designed to
include adequate control groups, and our observations would suggest that the
absence of one or more ofthe phases of EHF is a common spontaneous occurrence.
At any rate, the duration of the observed phases of the disease were consistent with
earlier reports [1,15,28].
Laboratory abnormalities included leukocytosis with shift to the left, observation
of atypical lymphocytes, thrombocytopenia, abnormal urinalysis (proteinuria, he-
51maturia, pyuria), azotemia, and electrolyte imbalance. These abnormalities have
been observed in virtually all previous studies of the disease [2,6,28]. There is no
obvious explanation as to why patients develop an elevated leukocyte count during
what is presumed to be a viral disease. Furthermore, regardless ofleukocytosis, tissue
infiltration of phagocytic cells is actually mild [7,29], suggesting that these cells may
not function normally.
Increase in blood urea nitrogen was seen in virtually every patient in whom this
was studied. Azotemia began to develop during thefever phase and generally reached
maximal elevation during the polyuria phase. Blood urea nitrogen returned to
normal in every patient who survived, which is consistent with the notion that EHF
has few, if any, long-term sequelae after recovery [2]. A recent Chinese study,
however, described persistent renal abnormalities as well as a variety of physical
complaints among survivors [30]. Acidosis and mild hyponatremia were common
electrolyte disturbances, and were undoubtedly due to the renal damage which has
been described in this disease[31], as well as hypotension and fluid imbalances [6,10].
Hyperkalemia, which was seen frequently among American soldiers with EHF [6],
was only rarely observed. Hypocalcemia was commonduringall phases ofthe disease
and may relate to protein abnormality, kidney damage, or other mechanisms.
The cumulative mortality rate of 11.2 percent which we observed is consistent with
the experience of other investigators in China [32], as well as workers in Korea [1]
and the USSR [25]. Mortality in Scandinavia from a related disease, Nephropa-
thica Epidemica, however, is rare [11]; this may relate to strain differences with
regards to the virulence of the etiologic agent [12,13,14,20,21,27,28,33].
In the present study, two patients died early in the course of disease as a result of
shock, whereas the remaining six patients died during the second or third week of
illness during the polyuria phase. Most of the patients who died had a variety of
abnormalities including azotemia, electrolyte imbalance, and central nervous system
abnormality. Although in other studies concerning the cause of death in EHF,
patients succumbed to the disease somewhat earlier in their course [6], the clinical
circumstances surrounding death are quite similar to the present study. Besides
primary shock, death has been attributed to uremia, secondary infection, pulmonary
edema, brain edema, and cerebral hemorrhage [6,7,16,28]. Spinal fluids obtained
from these patients have revealed mild pleocytosis with lymphocytes predominant
and elevated protein [28,34]. Spinal fluids occasionally have a yellow tinge which has
been attributed to azotemia, but xanthochromia or gross blood in the spinal fluid is
generally not observed.
It is probable that the central nervous system abnormalities reported (which
appear to be particularly common among patients who succumb to this infection)
involve a combination of electrolyte abnormality, azotemia, and cerebral edema, as
well as direct involvement of the brain [34]. Among autopsies of patients who died,
pituitary necrosis and mononuclear infiltration ofthe brain were frequently observed
[7,31].
Sera obtained from patients admitted to the First and Second Attached Hospitals
of Hubei Provincial Medical College were examined with respect to theformation of
antibodies directed against a variety ofagents known to produce hemorrhagicfevers.
The results of this study have been reported by Lee et al. [21] who demonstrated that
all the sera tested reacted with very high titers of antibodies directed against Korean
hemorrhagic fever virus antigen in the indirect immunofluorescence test and none of
the sera had significant concentrations of antibodies directed against several arbovi-
rus antigens in the hemagglutination-inhibition test. Chinese investigators have
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suggested that the formation of antigen antibody complexes may actually be
responsible for such abnormalities as renal damage and petechia, as well as triggering
of disseminated intervascular coagulation[35]. These workers have proposed therapy
directed against antibody formation [36]. Alternatively, immune sera obtained from
survivors could potentially ameliorate the course ofthe disease as has been suggested
for other hemorrhagic fevers [37].
The antigen of Korean hemorrhagic fever is prepared from the lungs ofwild mice
(Apodemus agrarius) endemic in several parts of Asia [17]. Transmission of the
disease appears to occur most commonly via the nasopharynegeal route by aerosol
infection, and outbreaks have occurred among animal trappers and laboratory
workers exposed to infected rodents [38,39]; nosocomial transmission, however, has
not been reported. Early studies designed by Soviet and Japanese investigators
demonstrated that blood and urine from patients with EHF contained an infectious
agent [28]. They also suggested that some of the insects harbored by wild mice could
transmit the disease although more recently Lee was unable to find EHF antigen in
ectoparasites collected from infected rodents [27].
Most of the patients in this study lived in the countryside area where exposure to
mice is common. Eighteen percent of the patients had known travel and/or living
conditions which may have increased the risk ofdeveloping EHF. These observations
are in agreement with a study in China by Xu and co-workers who observed an
increased incidence of EHF among adult male farm workers who slept in field shacks
[26]. They concluded that exposure to an airborne agent from rodent excrements
might explain their findings. KHF virus has been isolated from rodent saliva and
respiratory secretions [39], from Apodemus mouse urine (H.W. Lee, personal
communication) and from the feces and urine of Apodemus mice and Wistar rats
experimentally infected with KHF virus (P.W. Lee, unpublished data).
In summary, this study demonstrates that the clinical course of EHF among
patients in south central China is a disease similar to that described in Korea and the
USSR. Furthermore, the immunological response among this population of pa-
tients strongly suggests that EHF in China is produced by the same (or closely
related) agent as EHF in Korea [20,21], the USSR [17], and is closely related to the
agent of Nephropathica Epidemica in Scandinavia [12,13,14,27,33,39,40]. Many
questions concerning the morbidity, mortality, epidemiology, immunopathology,
and therapy of EHF remain to be answered.
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